Jump to content

Bio-IT World

Boston, MA, USA
April 15–17, 2024

Meet Genedata experts at Bio-IT World at booth #608 to learn how Genedata transforms data into intelligence with innovative software solutions that incorporate extensive biopharma R&D domain knowledge. Multinational biopharmaceutical organizations and cutting-edge biotechs around the globe rely on Genedata to digitalize and automate data-rich and complex R&D processes. From early discovery all the way to the clinic, Genedata solutions help maximize the ROI in R&D expenditure. Founded in 1997, Genedata is headquartered in Basel, Switzerland with additional offices in Boston, London, Munich, San Francisco, Singapore, and Tokyo.

Ask for a demonstration of Genedata solutions. For more about Genedata or to set up a meeting, please contact info(at)genedata.com.

Recommended Oral Presentations

Symposium: Digital Biopharma
Monday, April 15 | 8:00 am – 4:20 pm

The continued growth in volume, complexity, and variety of new modalities, including next-generation antibodies, cell and gene therapies, and vaccines, as well as the need to integrate data management and collaboration across discovery and into development requires a digital infrastructure to effectively collect, manage, model, and analyze data. The Digital Biopharma symposium explores the latest advances in data management and analytics used to increase process efficiency and quality and to identify the most promising drug candidates to quickly move forward from research into development.

Building Data Science Strategy for Translational Insight Generation with Genedata Profiler
Monday, April 15 | 2:35 pm
Kevin Tsai, PhD, Senior Director, Head of Data Engineering & Bioinformatics, Genmab

Dedicated to driving innovation and accelerating the development of transformative antibody-based oncology treatments, Genmab has implemented a robust data science strategy to help researchers realize their translational research goals. In this presentation, we will showcase how Genmab harnesses their Data Lakehouse Platform and Genedata Profiler to streamline multi-sourced data capture, improve data discoverability and access, and enhance self-service analytics. Supported by such a digital infrastructure, scientists can now easily derive scientific insights from diverse and complex R&D data, ultimately, making smarter decisions regarding novel disease targets, clinical biomarkers, or therapeutic indications

Recommended Poster Presentations

Artificial Intelligence Automates the Assignment of Biacore SPR and Octet BLI Kinetic Binding Profiles for a Faster Characterization of Lead Series | P18
Case R1, Wang W1, Chen Q1, Pfreundschuh M2, Siegismund D2, Florez J2, Wieser M2, McCamphill P2, Heyse S2 and SteigeleS2
1Amgen Inc, Thousand Oaks, California; 2Genedata AG, Basel, Switzerland

An Automated High Throughput Engineering Platform for AI-Supported Developability Predictions | P19
Kolinko S1, Rhabani D1, Dawkins E1, Sheng J2, Smith C3, Maillard K4, Freiberg S1
1Genedata AG, Basel, Switzerland | 2Genedata Inc., San Francisco, CA, USA | 3Genedata Inc., Boston, MA, USA | 4Genedata Ltd., London, UK


Learn More